Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.970
+0.52011.69%
Volume:56.86M
Turnover:276.25M
Market Cap:31.23B
PE:9.37
High:4.980
Open:4.680
Low:4.670
Close:4.450
52wk High:5.668
52wk Low:4.340
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:11.47
T/O Rate:0.91%
Dividend:0.14
Dividend Rate:2.83%
EPS(LYR):0.530
ROE:7.57%
ROA:2.66%
PB:0.55
PE(LYR):9.37
PS:0.11

Loading ...

Hong Kong Stock Announcement Highlights | GTHT Reports 220.74 Billion Yuan Net Profit in First Three Quarters, Up 131.8% YoY

Stock News
·
Oct 30, 2025

BRIEF-China Resources Pharmaceutical Says Fund Established With Proposed Size Of RMB500 Mln

Reuters
·
Oct 30, 2025

CR Pharma (3320) and CR Double-Crane (600062) Announce RMB500 Million Biomedical Fund

Bulletin Express
·
Oct 30, 2025

CHINARES PHARMA (03320) Leads Establishment of RMB 500 Million Fund, Focusing on Synthetic Biology and Innovative Drugs

Stock News
·
Oct 30, 2025

China Resources Pharmaceutical Group Ltd - Commits RMB123 Mln to Fund

THOMSON REUTERS
·
Oct 30, 2025

China Resources Pharmaceutical Group - Fund Established With Proposed Size of RMB500 Mln

THOMSON REUTERS
·
Oct 30, 2025

BRIEF-China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million

Reuters
·
Oct 27, 2025

China Resources Pharmaceutical (3320) Releases Key Financial Data of Subsidiary CR Boya Bio-pharmaceutical for the Nine Months Ended 30 September 2025

Bulletin Express
·
Oct 27, 2025

CHINARES PHARMA (03320): China Resources Boya Bio-Pharmaceutical Reports Q3 Net Profit of RMB 343 Million, Down 16.8% YoY

Stock News
·
Oct 27, 2025

China Resources Pharmaceutical - 9M Net Profit for Cr Boya Bio-Pharmaceutical RMB343 Mln

THOMSON REUTERS
·
Oct 27, 2025

China Resources Pharmaceutical Group Limited (Stock Code: 3320) Releases Key Financial Figures of Subsidiary CR Sanjiu for the First Three Quarters of 2025

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical Group Limited (3320) Announces KPC’s Unaudited Q3 2025 Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical (3320) Announces Jiangzhong Pharmaceutical’s Q3 2025 Financial Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical Group - 9 Months Revenue for Kpc Pharmaceuticals RMB4.75 Bln

THOMSON REUTERS
·
Oct 24, 2025

China Resources Pharmaceutical (3320) and Tasly Pharmaceutical Report Nine-Month 2025 Financial Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical (3320) Announces Dong-E-E-Jiao Q3 2025 Unaudited Financial Highlights

Bulletin Express
·
Oct 24, 2025

BRIEF-China Resources Pharmaceutical Reports 9M Revenue For Jiangzhong Pharmaceutical RMB 2.93 Billion

Reuters
·
Oct 24, 2025

China Resources Pharmaceutical (3320.HK) Announces CR Double-Crane Q3 2025 Financial Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical - 9M Net Profit for Jiangzhong Pharmaceutical RMB742.7 Mln

THOMSON REUTERS
·
Oct 24, 2025

CHINARES PHARMA (03320): Dong-E-E-Jiao Co., Ltd. Reports Net Profit of 1.277 Billion Yuan for First Three Quarters, Up 10.77% Year-on-Year

Stock News
·
Oct 24, 2025